DK0839148T3 - (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-on,O-[3-(3-methoxyphenyl)-2-propynyl]oximmaleat som et farmaceutisk middel - Google Patents

(R)-(Z)-1-azabicyclo[2.2.1]heptan-3-on,O-[3-(3-methoxyphenyl)-2-propynyl]oximmaleat som et farmaceutisk middel

Info

Publication number
DK0839148T3
DK0839148T3 DK96915757T DK96915757T DK0839148T3 DK 0839148 T3 DK0839148 T3 DK 0839148T3 DK 96915757 T DK96915757 T DK 96915757T DK 96915757 T DK96915757 T DK 96915757T DK 0839148 T3 DK0839148 T3 DK 0839148T3
Authority
DK
Denmark
Prior art keywords
heptan
azabicyclo
propynyl
methoxyphenyl
pharmaceutical
Prior art date
Application number
DK96915757T
Other languages
Danish (da)
English (en)
Inventor
Yoshihisa Ando Howard
Douglas Barrett Stephen
Carlos Jaen Juan
Edward Rose Steven
Haile Tecle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0839148T3 publication Critical patent/DK0839148T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
DK96915757T 1995-06-07 1996-05-13 (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-on,O-[3-(3-methoxyphenyl)-2-propynyl]oximmaleat som et farmaceutisk middel DK0839148T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/474,622 US5534522A (en) 1995-06-07 1995-06-07 (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
PCT/US1996/006814 WO1996040687A1 (en) 1995-06-07 1996-05-13 (r)-(z)-1-azabicyclo[2.2.1]heptan-3-one,o-[3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent

Publications (1)

Publication Number Publication Date
DK0839148T3 true DK0839148T3 (da) 2000-05-22

Family

ID=23884337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96915757T DK0839148T3 (da) 1995-06-07 1996-05-13 (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-on,O-[3-(3-methoxyphenyl)-2-propynyl]oximmaleat som et farmaceutisk middel

Country Status (25)

Country Link
US (1) US5534522A (xx)
EP (1) EP0839148B1 (xx)
JP (1) JPH11506723A (xx)
KR (1) KR100383031B1 (xx)
CN (1) CN1063181C (xx)
AT (1) ATE187967T1 (xx)
BG (1) BG63571B1 (xx)
CA (1) CA2219753A1 (xx)
CZ (1) CZ286528B6 (xx)
DE (1) DE69605800T2 (xx)
DK (1) DK0839148T3 (xx)
EA (1) EA000381B1 (xx)
EE (1) EE03971B1 (xx)
ES (1) ES2142586T3 (xx)
GE (1) GEP19991874B (xx)
GR (1) GR3032772T3 (xx)
HK (1) HK1018055A1 (xx)
HU (1) HUP9802499A3 (xx)
NO (1) NO308901B1 (xx)
NZ (1) NZ307946A (xx)
PL (1) PL323796A1 (xx)
SK (1) SK282824B6 (xx)
UA (1) UA46032C2 (xx)
WO (1) WO1996040687A1 (xx)
ZA (1) ZA964764B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
DK1670785T3 (da) * 2003-10-02 2010-10-18 Pharmacia & Upjohn Co Llc Salte og polymorphe former af en pyrrolsubstitueret indolinonforbindelse
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
US20090298814A1 (en) * 2005-06-07 2009-12-03 Ramot At Tel Aviv Univeristy Ltd Novel salts of conjugated psychotropic drugs and processes of preparing same
EP2275095A3 (en) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2051735B1 (en) 2006-07-17 2012-08-29 Ramot, at Tel Aviv University Ltd. Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders
BRPI0716604A2 (pt) 2006-09-08 2013-04-09 Braincells Inc combinaÇÕes contendo um derivado de 4-acilaminopiridina
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8207369B2 (en) 2008-02-11 2012-06-26 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
MX2012006566A (es) 2009-12-09 2012-11-29 Univ Ramot Metodo para mejorar las funciones cognoscitivas.
US8377929B2 (en) 2010-02-24 2013-02-19 Ramot At Tel-Aviv University Ltd. Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
US8916610B2 (en) 2010-09-22 2014-12-23 Ramot At Tel-Aviv University Ltd. Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
JP5997931B2 (ja) * 2011-05-25 2016-09-28 石原産業株式会社 農園芸用殺菌剤組成物及び植物病害の防除方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment

Also Published As

Publication number Publication date
SK282824B6 (sk) 2002-12-03
EA000381B1 (ru) 1999-06-24
GR3032772T3 (en) 2000-06-30
ZA964764B (en) 1997-01-08
DE69605800D1 (de) 2000-01-27
NO975704D0 (no) 1997-12-05
US5534522A (en) 1996-07-09
KR19990022572A (ko) 1999-03-25
HK1018055A1 (en) 1999-12-10
EE03971B1 (et) 2003-02-17
ES2142586T3 (es) 2000-04-16
EA199800007A1 (ru) 1998-06-25
HUP9802499A2 (hu) 1999-04-28
NZ307946A (en) 2001-03-30
CA2219753A1 (en) 1996-12-19
KR100383031B1 (ko) 2003-10-17
UA46032C2 (uk) 2002-05-15
BG63571B1 (bg) 2002-05-31
ATE187967T1 (de) 2000-01-15
NO308901B1 (no) 2000-11-13
SK164497A3 (en) 1998-06-03
NO975704L (no) 1998-01-30
EE9700316A (et) 1998-06-15
GEP19991874B (en) 1999-12-06
AU697954B2 (en) 1998-10-22
CZ381797A3 (cs) 1998-05-13
EP0839148B1 (en) 1999-12-22
CN1186493A (zh) 1998-07-01
HUP9802499A3 (en) 1999-06-28
CZ286528B6 (cs) 2000-05-17
EP0839148A1 (en) 1998-05-06
WO1996040687A1 (en) 1996-12-19
CN1063181C (zh) 2001-03-14
PL323796A1 (en) 1998-04-27
AU5744996A (en) 1996-12-30
JPH11506723A (ja) 1999-06-15
BG102078A (en) 1998-11-30
DE69605800T2 (de) 2000-11-16

Similar Documents

Publication Publication Date Title
DK0839148T3 (da) (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-on,O-[3-(3-methoxyphenyl)-2-propynyl]oximmaleat som et farmaceutisk middel
CA2333004A1 (en) Formoterol polymorphs
BR9810623B1 (pt) processo para a preparação de um sal de tartarato de um dipeptìdeo substituìdo como secretagogo de hormÈnio do crescimento, misturas enantioméricas ou seus enantiÈmeros, sal e composto.
CA2356300A1 (en) 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
AU6166996A (en) Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-((aminoiminomethyl)phenylalkyl)- azaheterocyclylamide compounds
WO2000076550A3 (de) Träger-pharmaka-konjugate
AU652778B2 (en) Treatment composition
ES2173422T3 (es) Disociacion de treo-metilfenidato.
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
CA2300289A1 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
CA2170645A1 (en) Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-14-indole-5-ethanesulphonamide
MX9708337A (es) Maleato (r)-(z)-1-azabiciclo [2.2.1]heptan-3-one,0-[3-(3-metoxifenil)-2-propinil]-oxime como un agente farmaceutico.
CA2360894A1 (en) (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
NO175565C (no) Fremgangsmåte for fremstilling av et parenteralt anvendbart, farmasöytisk preparat inneholdende et bis-indolalkaloid
EP1004586A3 (en) Method for producing 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine
CA2227194A1 (en) Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl]
AU2280895A (en) Synthesis n-protected amino acids, especially n-boc-l-propargylglycine by zinc-mediated addition or organic halides to glycine cation equivalent
CA2261706A1 (en) The use of growth factor modulating compounds
AU8660891A (en) 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds
AU6838690A (en) Organic amine phosphonic acid complexes
MX9701865A (es) Compuestos de dimetil-(3-aril-but-3-enil)-amino como ingredientes activos farmaceuticos.
AU619969C (en) Substituted 1-azabicyclo compounds
AU3281397A (en) Process for the preparation of organic salts of n'n-diacetylcystine
AU6496490A (en) Zak's railways click clack sound eliminator & softener
RU96124465A (ru) Способ лечения стойких дезадаптационных психовегетативных расстройств